Price Alert

Mustang Bio Inc. (MBIO)

NASDAQ: MBIO · Real-Time Price · USD

1.47

-0.07 (-4.55%)

At close: Sep 04, 2025, 3:59 PM

1.45

-1.36%

Pre-market: Sep 05, 2025, 09:21 AM EDT

-4.55% (1D)

About MBIO

undefined

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MBIO

Website n/a

2 months ago

+180.67%

Mustang Bio shares are trading higher after the co... Unlock content with Pro Subscription

2 months ago

+114.64%

Mustang Bio shares are trading higher after the company announced it received FDA Orphan Drug designation status for MB-101.

Mustang Bio surges 180% after its brain cancer therapy, MB-101, earns FDA Orphan Drug status for two rare brain tumor types.

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 400 points on Monday.

Shares of Mustang Bio (NASDAQ: MBIO) surged on Monday as investors responded to a significant approval from the Food and Drug Administration (FDA).